Ketamine Therapy in Palliative Care: Overcoming Systemic Hurdles

Integrating ketamine-assisted psychotherapy into palliative care requires significant infrastructure changes to address regulatory and reimbursement gaps. Palliative care programs face challenges in securing adequate resources and training to safely and effectively administer ketamine for managing end-of-life distress.

Systemic Sclerosis and TB What to Watch For

Patients with systemic sclerosis, already vulnerable due to immunosuppression and lung involvement, face a heightened risk of pulmonary tuberculosis. This case highlights the diagnostic and therapeutic challenges when TB mimics or masks ILD progression.

Cranial CT Scans Opportunistic Osteoporosis Screening Real World Policy Implications

Opportunistic osteoporosis screening using cranial CT scans could identify more patients at risk of major osteoporotic fractures. However, widespread implementation faces hurdles including medico-legal considerations and reimbursement complexities.

Atrial Fibrillation Complexity: How Reliable is Registry Data?

Patients with atrial fibrillation often present with a complex interplay of cardio-kidney-metabolic conditions, but large registry data can oversimplify these interactions. Clinicians should interpret such observational findings cautiously, especially when considering individual patient management.

Ketamine's Dissociative States and Palliative Care

For patients facing end-of-life distress, ketamine-assisted psychotherapy offers a novel approach by intentionally leveraging dissociative states. This reframes dissociation from a mere side effect to a potentially therapeutic mechanism, warranting careful consideration in palliative care settings.